HomeARQT • NASDAQ
add
Arcutis Biotherapeutics Inc
Previous close
$10.02
Day range
$9.62 - $10.05
Year range
$1.76 - $13.17
Market cap
1.14B USD
Avg Volume
2.07M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 30.86M | 494.57% |
Operating expense | 77.47M | 8.84% |
Net income | -52.33M | 26.28% |
Net profit margin | -169.59 | 87.60% |
Earnings per share | -0.42 | 63.79% |
EBITDA | -49.73M | 25.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 362.44M | 34.90% |
Total assets | 444.76M | 38.69% |
Total liabilities | 258.33M | 7.56% |
Total equity | 186.43M | — |
Shares outstanding | 116.89M | — |
Price to book | 6.26 | — |
Return on assets | -27.12% | — |
Return on capital | -30.32% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -52.33M | 26.28% |
Cash from operations | -45.12M | 32.14% |
Cash from investing | -62.14M | -169.72% |
Cash from financing | 1.46M | 36.36% |
Net change in cash | -105.83M | -546.36% |
Free cash flow | -27.04M | 33.96% |
About
Founded
2016
Headquarters
Website
Employees
296